Cargando…
Recombinant antibodies against Iranian cobra venom as a new emerging therapy by phage display technology
BACKGROUND: The production of antivenom from immunized animals is an established treatment for snakebites; however, antibody phage display technology may have the capacity to delivery results more quickly and with a better match to local need. Naja oxiana, the Iranian cobra, is a medically important...
Autores principales: | Nazari, Ali, Samianifard, Maedeh, Rabie, Hadi, Mirakabadi, Abbas Zare |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centro de Estudos de Venenos e Animais Peçonhentos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346683/ https://www.ncbi.nlm.nih.gov/pubmed/32695146 http://dx.doi.org/10.1590/1678-9199-JVATITD-2019-0099 |
Ejemplares similares
-
Cytotoxic Effect of Iranian Vipera lebetina Snake Venom on HUVEC Cells
por: Kakanj, Maryam, et al.
Publicado: (2015) -
Cobra Venom
Publicado: (1934) -
Cobra Venom in Therapeutics
por: Chopra, R. N., et al.
Publicado: (1937) -
Cobra Venom in Carcinoma
Publicado: (1935) -
Cytotoxic Effects of two Iranian Scorpions Odontobuthusdoriae and Bothutus saulcyi on Five Human Cultured Cell lines and Fractions of Toxic Venom
por: Ahmad Salarian, Amir, et al.
Publicado: (2012)